<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04860622</url>
  </required_header>
  <id_info>
    <org_study_id>NR TSH TURKEY</org_study_id>
    <nct_id>NCT04860622</nct_id>
  </id_info>
  <brief_title>Normal Range of TSH and FT4 in Pregnancy</brief_title>
  <acronym>NRTSHTURKEY</acronym>
  <official_title>Normal Range of TSH and FT4 in Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physiological changes necessitate the use of pregnancy-specific reference ranges for&#xD;
      thyrotrophin (TSH) and free T4 (FT4) to diagnose thyroid dysfunction during pregnancy.&#xD;
      Although many centers use fixed upper limits for TSH of 2.5 or 3.0 mU/L, this may lead to&#xD;
      overdiagnosis or even overtreatment.&#xD;
&#xD;
      The new guidelines of the American Thyroid Association have considerably changed&#xD;
      recommendations regarding thyroid function reference ranges in pregnancy accordingly. Any&#xD;
      hospital or physician that is still using the 2.5 or 3.0 mU/l cut-off for TSH during&#xD;
      pregnancy should evaluate their own lab-specific cut-offs.&#xD;
&#xD;
      The investigator's objective is to establish a rational reference range of serum TSH for the&#xD;
      diagnosis of subclinical hypothyroidism in the first, second, and third trimester of pregnant&#xD;
      women in the Sancaktepe region in Turkey.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Serum thyroid function tests (including T3, T4, TSH, Anti-TPO) will be obtained from the&#xD;
      singleton pregnancies in the first, second, and third trimester to determine the local&#xD;
      specific normal ranges.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Actual">September 1, 2021</completion_date>
  <primary_completion_date type="Actual">August 15, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>TSH</measure>
    <time_frame>On day 1</time_frame>
    <description>Trimester specific TSH level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>free T4</measure>
    <time_frame>On day 1</time_frame>
    <description>Trimester specific free T4 level</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">528</enrollment>
  <condition>Hypothyroidism</condition>
  <condition>Pregnancy Related</condition>
  <condition>Thyroid</condition>
  <condition>Dysfunction</condition>
  <condition>Iodine Deficiency</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <description>500 pregnant women with a singleton pregnancy, free of pre-existing thyroid disease, that do not use thyroid interfering medication, that did not undergo IVF treatment, and are TPOAb negative. Serum thyroid function tests will be obtained on the first visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum thyroid function tests</intervention_name>
    <description>At the first hospital visit, the blood tests will be made for TSH, FT4, FT3, and beta HCG concentration measurement</description>
    <arm_group_label>Pregnant women</arm_group_label>
    <other_name>Beta HCG and thyroid peroxidase antibody</other_name>
    <other_name>Thyroid ultrasonography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Turkish pregnant women living in Sancaktepe Region of Turkey&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  Free of pre-existing thyroid disease&#xD;
&#xD;
          -  That do not use thyroid interfering medication&#xD;
&#xD;
          -  That did not undergo IVF treatment&#xD;
&#xD;
          -  TPOAb negative&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adolescent pregnancy&#xD;
&#xD;
          -  Patient with pre-existing thyroid disease&#xD;
&#xD;
          -  TPOAb positive&#xD;
&#xD;
          -  Patient using thyroid interfering medication&#xD;
&#xD;
          -  That had IVF treatment&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Murat Yassa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Specialist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sehit Prof Dr Ilhan Varank Sancaktepe Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017 Mar;27(3):315-389. doi: 10.1089/thy.2016.0457. Erratum in: Thyroid. 2017 Sep;27(9):1212.</citation>
    <PMID>28056690</PMID>
  </reference>
  <reference>
    <citation>Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem. 2001 Jul;38(Pt 4):329-32.</citation>
    <PMID>11471873</PMID>
  </reference>
  <reference>
    <citation>Donovan LE, Metcalfe A, Chin A, Yamamoto JM, Virtanen H, Johnson JA, Krause R. A Practical Approach for the Verification and Determination of Site- and Trimester-Specific Reference Intervals for Thyroid Function Tests in Pregnancy. Thyroid. 2019 Mar;29(3):412-420. doi: 10.1089/thy.2018.0439. Epub 2019 Feb 4.</citation>
    <PMID>30595114</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 22, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Arzu Bilge Tekin</investigator_full_name>
    <investigator_title>Specialist M.D.</investigator_title>
  </responsible_party>
  <keyword>Hypothyroidism</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>trimester</keyword>
  <keyword>thyroid dysfunction</keyword>
  <keyword>iodine level</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

